Ocugen
- All
- News
- Videos
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
-
Bharat Biotech's US Partner Files Request With FDA For Covaxin Trials
Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration to conduct clinical trials.
-
US Delays Use Of India-Made COVID-19 Vaccine Covaxin. What It Recommended
In a setback to Bharat Biotech's COVID-19 vaccine Covaxin, the US Food and Drug Administration has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data.
-
Ocugen, Bharat Biotech To Co-Develop Covaxin For US: Report
Drug developer Ocugen Inc said on Tuesday it had partnered with Bharat Biotech to co-develop the Hyderabad-based company's COVID-19 vaccine candidate for the US market.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
-
Bharat Biotech's US Partner Files Request With FDA For Covaxin Trials
Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration to conduct clinical trials.
-
US Delays Use Of India-Made COVID-19 Vaccine Covaxin. What It Recommended
In a setback to Bharat Biotech's COVID-19 vaccine Covaxin, the US Food and Drug Administration has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data.
-
Ocugen, Bharat Biotech To Co-Develop Covaxin For US: Report
Drug developer Ocugen Inc said on Tuesday it had partnered with Bharat Biotech to co-develop the Hyderabad-based company's COVID-19 vaccine candidate for the US market.
